SYNAPS DX
Synaps Dx is a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease.
SYNAPS DX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.synapsdx.com
Total Employee:
1+
Status:
Active
Total Funding:
10 M USD
Technology used in webpage:
Organization Schema Squarespace Hosted
Similar Organizations
Braegen Pharmaceutical
The company is developing drugs for neurodegenerative diseases including Alzheimer’s disease.
Clene Nanomedicine
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
Critical Diagnostics
Critical Diagnostics is engaged in the R&D and commercialization of novel biomarkers in cardiovascular diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Employees Featured
Frank Amato CEO & President @ Synaps Dx
CEO & President
Paul Tanico Executive Chairman & Co-founder @ Synaps Dx
Executive Chairman & Co-founder
2016-01-01
Dr. Daniel Alkon Chief Scientific Advisor @ Synaps Dx
Chief Scientific Advisor
Founder
Investors List
Semler Scientific
Semler Scientific investment in Corporate Round - Synaps Dx
Bull & Bear
Bull & Bear investment in Series A - Synaps Dx
Official Site Inspections
http://www.synapsdx.com Semrush global rank: 9.03 M Semrush visits lastest month: 445
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Synaps Dx"
About SynapsDX | Synaps DX
In addition of being appointed Dean ad interim, for his services to the research and educational mission of UTMB, over the years Dr. Taglialatela has received numerous awards, including, in …See details»
SYNAPS Dx - An Alzheimer's Disease Diagnostic company
Info@synapsdx.com +1 (301) 294-7180. This test was developed, and its performance characteristics determined by NeuroDiagnostics Inc, dba Synaps Dx. It has not been cleared …See details»
Synaps Dx - Crunchbase Company Profile & Funding
Organization. Synaps Dx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
SYNAPS Dx - An Alzheimer's Diagnostic company
Synaps Dx is dedicated to transforming the diagnosis of Alzheimer’s disease (AD). Operating a CLIA-certified laboratory, we offer DISCERN™, the first commercially available test to accurately ...See details»
SYNAPS Dx - An Alzheimer's Diagnostic company Overview
Organization Website. synapsdx.com . Phone Number. 301-294-7026. SYNAPS Dx - An Alzhe... industries. Biotech Headquarters Location. 12441 Parklawn Dr, Rockville, MD, 20852 US. …See details»
SYNAPS Dx 2025 Company Profile: Valuation, Funding & Investors
SYNAPS Dx General Information Description. Developer of Alzheimer's disease diagnostic tool designed to commercialize the biomarker technology. The company research develops and …See details»
SYNAPS Dx Company Profile | Management and Employees List
JohnSmith@synapsdx.com: 5: first_last: John_Smith@synapsdx.com: 6: last: Smith@synapsdx.com: Your Questions, Our Answers Get Free Access to SYNAPS Dx …See details»
Our Values | Synaps DX
Info@synapsdx.com +1 (301) 294-7180. This test was developed, and its performance characteristics determined by NeuroDiagnostics Inc, dba Synaps Dx. It has not been cleared …See details»
SYNAPS Dx CEO Frank Amato Presents at HolonIQ, …
Sep 20, 2022 Contact: info@synapsdx.com. Contacts. Media: Caroline Chambers CPR Communications cchambers@cpronline.com 201.641.1911 x 21 Release Summary.See details»
SYNAPS Dx - Overview, News & Similar companies | ZoomInfo.com
Oct 31, 2023 www.synapsdx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. SYNAPS Dx Announces Prestigious Scientific …See details»
Spotlight Interview: Frank Amato, President and CEO, …
Medical Travel & Digital Health News (MTDHN): How did both of you get involved with SYNAPS Dx? Dr. Daniel Alkon (DA): I spent much of my career as an academician, program director and laboratory chief at the National Institute of …See details»
SYNAPS Dx Completes $10 Million Series A Investment, …
Oct 12, 2021 SYNAPS Dx Completes $10 Million Series A Investment, Accelerates Commercialization of DISCERN for Accurate Diagnosis of Alzheimer’s DiseaseSee details»
Synaps Dx Launches Digital Cognitive Screening and Alzheimer’s …
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our …See details»
SYNAPS Dx Names Leading Healthcare Executives and Innovators …
Dec 15, 2021 Contact: info@synapsdx.com. Contacts. Media: Brittany Tedesco CPR Communications btedesco@cpronline.com 201.641.1911 x 14 Release Summary.See details»
SYNAPS Dx Welcomes Renowned Alzheimer’s Researcher, Dr.
SYNAPS Dx welcomes Dr. Donna M. Wilcock, a leading Alzheimer's researcher, to its Scientific Advisory Board. Dr. Wilcock's expertise in neuroinflammation and...See details»
Science - SYNAPS Dx
Info@synapsdx.com +1 (301) 294-7180. This test was developed, and its performance characteristics determined by NeuroDiagnostics Inc, dba Synaps Dx. It has not been cleared …See details»
SYNAPS Dx DISCERN™ Test Provides Accurate Diagnosis of …
Jul 11, 2023 SYNAPS Dx (SDx) a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recognizes the …See details»
SYNAPS Dx Opens High-Tech Laboratory Supporting Research ...
Aug 9, 2022 Contact: info@synapsdx.com. Contacts. Media: Caroline Chambers CPR Communications cchambers@cpronline.com 201.641.1911 x 21 Release Summary.See details»
SYNAPS Dx Announces Investment by Semler Scientific: Advances ...
Mar 2, 2022 Contact: info@synapsdx.com. Contacts. Media: Brittany Tedesco CPR Communications btedesco@cpronline.com 201.641.1911 x 14 Release Summary.See details»
SYNAPS Dx Selects Dallas/Fort Worth Texas Markets as First …
Jul 12, 2022 Contact: info@synapsdx.com. Contacts. Media: Caroline Chambers CPR Communications cchambers@cpronline.com 201.641.1911 x 21 Release Summary.See details»